BETA technical summary

At ₹1,806.6, Beta Drugs Limited is trading 12.2% below its 50-day average of ₹2,057.07 and 5.3% above its 200-day average of ₹1,715.68. The 14-day RSI is 45.3, in the neutral range between 30 and 70. MACD is -47.28 against a signal line of -71.03, so the MACD line sits above its signal line. ADX(14) reads 15.9, a weak trend reading (below 20); ADX measures trend strength, not direction. The 52-week range is ₹990.1 to ₹2,807.9, with the price 45% of the way up it. Classic daily pivot levels from the 29 Oct 2026 session: pivot ₹1,939.87, resistance ₹2,056.93 and ₹2,137.07, support ₹1,859.73 and ₹1,742.67.